Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · SHOULDER INNOVATIONS, INC. (SI)

Shoulder Innovations begins limited user release of next-generation InSet Go implant

Neutral Impact 2 of 5 product/contract Written later

Shoulder Innovations announced a limited user release of the InSet Go, its next-generation glenoid implant, after the first surgical case was completed at University Hospitals Cleveland Medical Center. The filing contains no financial figures, and the company said it expects a full commercial introduction over the coming quarters, so the news is an early step in the product's rollout.

Key points

  • First surgical case using InSet Go was performed by Robert Gillespie, MD, at University Hospitals Cleveland Medical Center, Cleveland, OH
  • The company says InSet Go reduces surgical steps and offers the potential for reduced procedure times
  • Full commercial introduction is expected over the coming quarters, according to CEO Rob Ball
  • The filing reports no revenue, earnings or guidance figures

The filing

CompanySHOULDER INNOVATIONS, INC. (SI)
Form8-K, current report
Filed with the SECOct 8, 2026, 7:05 AM ET
Accession number0001699350-26-000058

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 08, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.